Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1963 1
2017 2
2018 3
2019 2
2020 7
2021 6
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis.
Ytterberg SR, Bhatt DL, Mikuls TR, Koch GG, Fleischmann R, Rivas JL, Germino R, Menon S, Sun Y, Wang C, Shapiro AB, Kanik KS, Connell CA; ORAL Surveillance Investigators. Ytterberg SR, et al. Among authors: rivas jl. N Engl J Med. 2022 Jan 27;386(4):316-326. doi: 10.1056/NEJMoa2109927. N Engl J Med. 2022. PMID: 35081280 Clinical Trial.
Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance.
Charles-Schoeman C, Buch MH, Dougados M, Bhatt DL, Giles JT, Ytterberg SR, Koch GG, Vranic I, Wu J, Wang C, Kwok K, Menon S, Rivas JL, Yndestad A, Connell CA, Szekanecz Z. Charles-Schoeman C, et al. Among authors: rivas jl. Ann Rheum Dis. 2023 Jan;82(1):119-129. doi: 10.1136/ard-2022-222259. Epub 2022 Sep 22. Ann Rheum Dis. 2023. PMID: 36137735 Free PMC article.
SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDS.
Juanes-Velasco P, Landeira-Viñuela A, García-Vaquero ML, Lecrevisse Q, Herrero R, Ferruelo A, Góngora R, Corrales F, Rivas JL, Lorente JA, Hernández ÁP, Fuentes M. Juanes-Velasco P, et al. Among authors: rivas jl. Front Immunol. 2022 Jan 28;13:732197. doi: 10.3389/fimmu.2022.732197. eCollection 2022. Front Immunol. 2022. PMID: 35154090 Free PMC article.
Impact of cardiovascular risk enrichment on incidence of major adverse cardiovascular events in the tofacitinib rheumatoid arthritis clinical programme.
Dougados M, Charles-Schoeman C, Szekanecz Z, Giles JT, Ytterberg SR, Bhatt DL, Koch GG, Vranic I, Wu J, Wang C, Kwok K, Menon S, Connell CA, Yndestad A, Rivas JL, Buch MH. Dougados M, et al. Among authors: rivas jl. Ann Rheum Dis. 2023 Apr;82(4):575-577. doi: 10.1136/ard-2022-223406. Epub 2023 Jan 31. Ann Rheum Dis. 2023. PMID: 36720582 Free PMC article. No abstract available.
Joining European Scientific Forces to Face Pandemics.
Vasconcelos MH, Alcaro S, Arechavala-Gomeza V, Baumbach J, Borges F, Brevini TAL, Rivas JL, Devaux Y, Hozak P, Keinänen-Toivola MM, Lattanzi G, Mohr T, Murovska M, Prusty BK, Quinlan RA, Pérez-Sala D, Scheibenbogen C, Schmidt HHHW, Silveira I, Tieri P, Tolios A, Riganti C. Vasconcelos MH, et al. Among authors: rivas jl. Trends Microbiol. 2021 Feb;29(2):92-97. doi: 10.1016/j.tim.2020.10.008. Epub 2020 Dec 4. Trends Microbiol. 2021. PMID: 33288385 Free PMC article.
Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID.
Rodríguez-Hernández G, Opitz FV, Delgado P, Walter C, Álvarez-Prado ÁF, González-Herrero I, Auer F, Fischer U, Janssen S, Bartenhagen C, Raboso-Gallego J, Casado-García A, Orfao A, Blanco O, Alonso-López D, Rivas JL, Tena-Dávila SG, Müschen M, Dugas M, Criado FJG, Cenador MBG, Vicente-Dueñas C, Hauer J, Ramiro AR, Sanchez-Garcia I, Borkhardt A. Rodríguez-Hernández G, et al. Among authors: rivas jl. Nat Commun. 2019 Dec 5;10(1):5563. doi: 10.1038/s41467-019-13570-y. Nat Commun. 2019. PMID: 31804490 Free PMC article.
Germline variants in early and late-onset Brazilian prostate cancer patients.
Coelho KBCA, Squire JA, Duarte KG, Sares CTG, Moreda NA, Pereira JL, da Silva IT, Defelicibus A, Aoki MN, Rivas JL, Dos Reis RB, Zanette DL. Coelho KBCA, et al. Among authors: rivas jl. Urol Oncol. 2024 Mar;42(3):68.e11-68.e19. doi: 10.1016/j.urolonc.2024.01.015. Epub 2024 Feb 3. Urol Oncol. 2024. PMID: 38311546
26 results